What a GLP-1 program really costs in 2026?

Online GLP-1 programs in the US run roughly $99 to $348 a month in 2026, and almost all of them increase as your dose increases. The GLP Doctor charges $149 a month at any dose. Insurance coverage, where it exists, changes the figure entirely.

The advertised price is a starting price

Look at how these offers are written. The number in the ad is nearly always the entry dose, month one, first order, sometimes with a promotional discount folded in. It is a real price. It just isn't the price you'll be paying in October.

That's not a scandal on its own - dose-based pricing is a normal way to sell a drug that costs more to supply at higher strengths. The problem is that patients are asked to compare programs on a number that describes month one and then live with the number that shows up in month six.

How much does semaglutide cost per month in 2026?

For cash-pay telehealth, the honest answer is a range rather than a figure: roughly $99 to $348 a month depending on the provider, the dose and what's bundled in. Four different payment routes sit behind that range, and they behave very differently.

Route: Insurance

Typical monthly cost: Copay only, if covered

What it depends on?: Plan formulary, prior authorization, employer's benefit design

The catch: Coverage for weight management is patchy and employers have been dropping it

Route: Manufacturer self-pay

Typical monthly cost: [VERIFY: current published self-pay prices]

What it depends on?: Product, dose, eligibility rules

The catch: Terms change; check the manufacturer's own page on the day

Route: Telehealth cash-pay

Typical monthly cost: ~$99–$348

What it depends on?: Provider, dose tier, add-on fees

The catch: Most tiers rise with the dose

Route: 503A compounded

Typical monthly cost: Varies by pharmacy and provider

What it depends on?: An individualized clinical reason documented by your prescriber

The catch: Not FDA-approved; not reviewed by FDA for safety, effectiveness or quality

Why the bill jumps in month four?

Titration is why. Most people don't start on a maintenance dose; they build up over weeks or months under a prescriber's supervision. On a dose-tiered program, every step up is also a price step up.

So the arithmetic that felt comfortable in week one quietly changes. Here's the same year, two ways, using the bottom and top of the 2026 market range as an illustration.

Month - 1–3

Escalating program (illustrative) - $99

Flat program at $149 - $149

Month - 4–6

Escalating program (illustrative) - ~$225

Flat program at $149 - $149

Month - 7–12

Escalating program (illustrative) - $348

Flat program at $149 - $149

Twelve-month total for escalating program - $3,060

Twelve-month total for flat program - $1,788

That escalating column is an illustration built from published market endpoints, not a quote from any named competitor. Your actual ladder depends on the program you pick, and you should ask for it in writing before you enter a card number.

The pattern holds even when the numbers move. A low entry price paired with a steep ladder usually beats a flat price for about a quarter, then loses for the rest of the year.

The line items nobody puts in the ad

Membership or subscription fees, charged separately from medication. Consultation fees for the initial evaluation, and sometimes for follow-ups. Shipping, especially for cold-chain items. Lab work, where a provider requires it. Cancellation terms, which occasionally mean paying for a month you didn't want.

None of those are unreasonable in themselves. They're only a problem when they're discovered in month two. Ask about all five before you commit - a program that answers plainly is telling you something good about itself.

What the new orals do to the price map?

FDA approved oral semaglutide 25 mg on 22 December 2025 and orforglipron (Foundayo) on 1 April 2026. Two more approved products in the market changes the competitive picture, and cash-pay pricing tends to follow competition rather than lead it. Whether that reaches your monthly bill in 2026 or 2027 is genuinely unknown, and anyone telling you otherwise is guessing.

Where compounded preparations sit?

Since FDA declared the semaglutide shortage resolved on 21 February 2025 and the tirzepatide shortage resolved on 2 October 2024, 503B batch compounding of these molecules has been closed off. 503A patient-specific compounding remains lawful where a prescriber documents an individualized clinical reason the commercially available product doesn't meet - a dose that isn't commercially available, for instance.

Price is not a clinical reason, and a cheaper compounded preparation is not a substitute for an approved drug on any measure FDA has reviewed. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. The regulatory detail is in the 2026 compounding rules.

Five questions to ask before you pay

1. What will I pay at every dose, not just the first one?

2. Is there a membership, consultation or lab fee on top?

3. Is shipping included, and is it cold-chain where needed?

4. What happens to my price if my prescriber holds me at a lower dose for longer?

5. How do I cancel, and what's the notice period?

How our pricing works?

The GLP Doctor charges $149 a month at any dose. That's the whole point of it: nobody at our end gains from moving you up a step, and nobody loses if your prescriber decides you're doing well where you are. That matters most for people who titrate slowly, who are penalized hardest by dose-tiered billing.

Shipping is free over $150 and there's no membership fee. Providers are licensed in all 50 states, the service is LegitScript-approved, and we work with 503A-compliant compounding partners. [CONFIRM: whether an initial consultation fee or lab fee applies] [CONFIRM: cancellation terms] You can see how the evaluation works before signing up for anything, and the program page has the current terms: $149 a month at any dose.

Everything here is prescription-only and follows an evaluation by a licensed provider; not everyone is eligible. Wegovy, Ozempic, Zepbound, Mounjaro and Foundayo are trademarks of their respective owners and are named descriptively.

Frequently asked questions

What's the cheapest legitimate route? It depends on your insurance. If your plan covers weight management, that's almost always cheapest. If it doesn't, compare full-year totals rather than month-one prices.

Does a higher dose cost you more here? No. Same $149 at any dose.

Will insurance cover it in 2026? Sometimes, and less often than it did. Employer benefit designs have tightened. Check your formulary and whether prior authorization is required.

Is compounded cheaper? Sometimes, but cost can't be the reason it's prescribed. It has to be an individualized clinical decision.

Should I prepay for a year to get a discount? Only if you're confident you'll tolerate the medication. People stop for all sorts of reasons in the first three months.